Publication | Closed Access

Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: Anti-inflammatory effect in experimental asthmatic rats

AsthmaInhalable Powder FormulationInflammationAnti-inflammatoryMedicineAnti-inflammatory EffectImmunologyPharmacologyExperimental Asthmatic RatsGastrointestinal Peptide Hormone